Lin, Haiping
Yu, Minhao
Ye, Guangyao
Qin, Shaolan
Fang, Hongsheng
Jing, Ran
Gong, Tingyue
Luo, Yang
Zhong, Ming
Funding for this research was provided by:
National Natural Science Foundation of China (81802308, 81873555)
Science and Technology Commission of Shanghai Municipality (19411966200)
Article History
Received: 9 May 2022
Accepted: 23 August 2022
First Online: 9 September 2022
Declarations
:
: This study was approved by the Ethics Committee of of the Renji Hospital, Shanghai Jiao Tong University School of Medicine. Written informed consent was obtained from all the participants and no participant was under 16. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, and all methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Drs. Haiping Lin, Minhao Yu, Guangyao Ye, Shaolan Qin; Hongsheng Fang, Ran Jing, Tingyue Gong, Yang Luo, Ming Zhong have no conflicts of interest or financial ties to disclose. For patients receiving intracorporeal reinforcement with V-LOCTM barbed suture (3-0) (COVIDIEN, Beijing, China), no reduced costs or other financial interets will be offered by the company.